Thor Medical ASA (OSL:TRMED)
kr 1.018 0.014 (1.39%) Market Cap: 239.09 Mil Enterprise Value: 210.39 Mil PE Ratio: 0 PB Ratio: 0.93 GF Score: 39/100

Q1 2020 Nordic Nanovector ASA Earnings Call Transcript

May 26, 2020 / 06:30AM GMT
Release Date Price: kr20.26 (-12.00%)
Lars Nieba
Nordic Nanovector ASA - Interim CEO & CTO

Good morning, everyone. I would like to welcome you to the audiocast for Nordic Nanovector's Q1 Results. I'm Lars Nieba, the interim CEO of Nordic Nanovector and, as mentioned by the speaker, we have Jan Egberts with us, our Chairman; Malene Brondberg, our new CFO; and Marco Renoldi, our COO.

Let me first go to the next slide, which is the forward-looking statement. As usual, we do have that. And on the next slide, I would like to introduce our management team with a lot of international experience. We do have Dominic Smethurst, our Chief Medical Officer; Marco, who most of you probably know, our Chief Operating Officer; Rosemarie Corrigan, our Chief Quality Officer; our new CFO, Malene Brondberg; Jostein Dahle, our Co-Founder and Chief Scientific Officer; and Gabriele Elbl, our Vice President for Global Regulatory Affairs.

On the next slide, I would like to guide you through our Q1 highlights. As you've probably read in February, I was appointed as the Interim Chief Executive Officer. In March, we appointed Dominic Smethurst as

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot